Health Affairs January 30, 2023
Patients and hospitals routinely cannot access the most basic and essential prescription medications due to shortages of drugs such as amoxicillin, Adderall, saline, and epinephrine. The recent COVID-19 pandemic and associated geopolitical challenges have further highlighted the need to proactively identify and address vulnerabilities in US pharmaceutical supply chains.
Numerous reports have been written by government agencies, academics, think tanks, consulting companies, and other industry participants to systematically identify causes of and potential solutions to these challenges. One of these efforts was Building Resilience into the Nation’s Medical Product Supply Chains, from the National Academies of Sciences, Engineering, and Medicine (NASEM) , to which this article’s authors contributed as authors or consultants. (The report was commissioned in response to Congress’...
Today's Sponsors
Today's Sponsor